Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Econazole/Benzydamine Intravaginal Cream in Healthy Women
NCT02713893Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of econazole and benzydamine in vulvovaginal candidiasis (VVC) (4 arms), sponsored by Angelini Pharma. Primary endpoint: Local Adverse Events. Started Sep 2015; status: completed.
02
Drugs
econazolebenzydamine
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT02713893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713893.